TCL Archive Rabson Recommended For NCI Acting Director, Will be Top Prospect For Permanent Appointment August 26, 1988
TCL Archive FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug July 26, 2013